Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Dec 18;109(51):E3528; author reply E3529.
doi: 10.1073/pnas.1216417109. Epub 2012 Nov 6.

Vitamin D and tuberculosis

Andrew Grey, Mark Bolland
Comment

Vitamin D and tuberculosis

Andrew Grey et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

  • Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.
    Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR. Coussens AK, et al. Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15449-54. doi: 10.1073/pnas.1200072109. Epub 2012 Sep 4. Proc Natl Acad Sci U S A. 2012. PMID: 22949664 Free PMC article. Clinical Trial.

References

    1. Coussens AK, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA. 2012;109(38):15449–15454. - PMC - PubMed
    1. Martineau AR, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377(9761):242–250. - PMC - PubMed
    1. Wejse C, et al. Vitamin D as supplementary treatment for tuberculosis: A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179(9):843–850. - PubMed
    1. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266(1):93–98. - PubMed
    1. Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ. 2001;322(7292):989–991. - PMC - PubMed